The tubular excretion of benzylpenicillin in patients with cystic fibrosis.

Abstract

1 The tubular excretion of benzylpenicillin (BP) was investigated in six volunteers with cystic fibrosis. 2 The volunteers received a continuous infusion of BP at increasing infusion rates in order to maintain constant plasma concentrations at three different levels. Blood and urine samples were taken every 30 min. Sufficient urinary flow was ensured by a saline infusion (500 ml h-1).3 The renal clearance of BP was calculated for the non-protein bound fraction of the drug. 4 Tubular clearance and tubular excretion rate were estimated from the renal clearance of the antibiotic minus the glomerular filtration rate; the latter was considered to be equal to creatinine clearance.5 The data were analysed according to a Scatchard plot and values for ECU50 and maximal tubular excretion rate were calculated. The mean value of ECU50 was 89 ± 24 (mg 1-l ± s.d.) and that for the maximal tubular excretion rate was 2603 ± 714 (mg h-1 + s.d.).The latter value was significantly less than that found in a previous study of healthy volunteers, but the ECU50 was similar. 6 It is concluded that the tubular excretory capacity for BP is decreased in patients with cystic fibrosis in direct relation to their low body weight.

Tratamiento antimicrobiano frente a la colonización pulmonar por Pseudomonas aeruginosa en el paciente con fibrosis quística

“…En los β-lactámicos, la función renal desempeña un papel importante en el perfil farmacocinético, ya que en su mayoría se eliminan a través del riñón. Los resultados de los diversos ensayos en los que se estudia la función renal de los pacientes con FQ no han mostrado diferencias en el aclaramiento renal cuando se compara con el resto de la población [116][117][118][119] . En cualquier caso, tanto el GFR como la secreción tubular aparecen conservadas en estos pacientes.…”